SB 239063
A potent, selective, orally available p38 MAPK inhibitor with IC50 of 44 nM for both p38α and p38β; shows no activity (>100 μM) against the γ- and δ-kinase isoforms, and a panel of protein kinase; inhibits IL-1 and TNF-alpha production in LPS-stimulated human PBMCs (IC50= 0.12 and 0.35 uM) ; reduces inflammatory cytokine production, airways eosinophil infiltration and persistence in vivo.
Product Specifications
CAS Number
193551-21-2
Product Name Alternative
SB-239063 | SB239063
Purity
>98% (HPLC)
Solubility
10 mM in DMSO
Smiles
O[C@H]1CC[C@H] (N2C (C3=NC (OC) =NC=C3) =C (C4=CC=C (F) C=C4) N=C2) CC1
Molecular Formula
C20H21FN4O2
Molecular Weight
368.4048
Storage Conditions
Storage temperature: -20°C. Stability: ≥ 2 years
Notes
For research use only.
Other Product Names
Cyclohexanol, 4-[4- (4-fluorophenyl) -5- (2-methoxy-4-pyrimidinyl) -1H-imidazol-1-yl]-, trans-
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
ERb22441 96 Tests
Rabbit NEFL (Neurofilament, Light Polypeptide) ELISA Kit
Sign In for Pricing
View Details 
K6896406 1.0 µg DNA
Utrn sgRNA CRISPR/Cas9 All-in-One Lentivector (Rat) (Target 1)
Sign In for Pricing
View Details